The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Weight Loss and Obesity Management Market Research Report 2025
Synopsis
The global Weight Loss and Obesity Management market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Weight Loss and Obesity Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Weight Loss and Obesity Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Weight Loss and Obesity Management in Men is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Weight Loss and Obesity Management include Novo Nordisk, GlaxoSmithKline, Roche, Allergan, Johnson & Johnson, Medtronic, Vivus Inc, Eisai and Nalpropion Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Weight Loss and Obesity Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Weight Loss and Obesity Management.
Report Scope
The Weight Loss and Obesity Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Weight Loss and Obesity Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Weight Loss and Obesity Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
GlaxoSmithKline
Roche
Allergan
Johnson & Johnson
Medtronic
Vivus Inc
Eisai
Nalpropion Pharmaceuticals
ReShape Lifesciences
Obalon Therapeutics
Allurion Technologies
Beijing Noble Laser Technology
Segment by Type
Weight Loss and Obesity Management Devices
Weight Loss and Obesity Management Drugs
Segment by Application
Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Weight Loss and Obesity Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Weight Loss and Obesity Management market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Weight Loss and Obesity Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Weight Loss and Obesity Management is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Weight Loss and Obesity Management in Men is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Weight Loss and Obesity Management include Novo Nordisk, GlaxoSmithKline, Roche, Allergan, Johnson & Johnson, Medtronic, Vivus Inc, Eisai and Nalpropion Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Weight Loss and Obesity Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Weight Loss and Obesity Management.
Report Scope
The Weight Loss and Obesity Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Weight Loss and Obesity Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Weight Loss and Obesity Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
GlaxoSmithKline
Roche
Allergan
Johnson & Johnson
Medtronic
Vivus Inc
Eisai
Nalpropion Pharmaceuticals
ReShape Lifesciences
Obalon Therapeutics
Allurion Technologies
Beijing Noble Laser Technology
Segment by Type
Weight Loss and Obesity Management Devices
Weight Loss and Obesity Management Drugs
Segment by Application
Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Weight Loss and Obesity Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Weight Loss and Obesity Management Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Weight Loss and Obesity Management Devices
1.2.3 Weight Loss and Obesity Management Drugs
1.3 Market by Application
1.3.1 Global Weight Loss and Obesity Management Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Weight Loss and Obesity Management Market Perspective (2019-2030)
2.2 Weight Loss and Obesity Management Growth Trends by Region
2.2.1 Global Weight Loss and Obesity Management Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Weight Loss and Obesity Management Historic Market Size by Region (2019-2024)
2.2.3 Weight Loss and Obesity Management Forecasted Market Size by Region (2025-2030)
2.3 Weight Loss and Obesity Management Market Dynamics
2.3.1 Weight Loss and Obesity Management Industry Trends
2.3.2 Weight Loss and Obesity Management Market Drivers
2.3.3 Weight Loss and Obesity Management Market Challenges
2.3.4 Weight Loss and Obesity Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Weight Loss and Obesity Management Players by Revenue
3.1.1 Global Top Weight Loss and Obesity Management Players by Revenue (2019-2024)
3.1.2 Global Weight Loss and Obesity Management Revenue Market Share by Players (2019-2024)
3.2 Global Weight Loss and Obesity Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Weight Loss and Obesity Management Revenue
3.4 Global Weight Loss and Obesity Management Market Concentration Ratio
3.4.1 Global Weight Loss and Obesity Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Weight Loss and Obesity Management Revenue in 2023
3.5 Weight Loss and Obesity Management Key Players Head office and Area Served
3.6 Key Players Weight Loss and Obesity Management Product Solution and Service
3.7 Date of Enter into Weight Loss and Obesity Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Weight Loss and Obesity Management Breakdown Data by Type
4.1 Global Weight Loss and Obesity Management Historic Market Size by Type (2019-2024)
4.2 Global Weight Loss and Obesity Management Forecasted Market Size by Type (2025-2030)
5 Weight Loss and Obesity Management Breakdown Data by Application
5.1 Global Weight Loss and Obesity Management Historic Market Size by Application (2019-2024)
5.2 Global Weight Loss and Obesity Management Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Weight Loss and Obesity Management Market Size (2019-2030)
6.2 North America Weight Loss and Obesity Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Weight Loss and Obesity Management Market Size by Country (2019-2024)
6.4 North America Weight Loss and Obesity Management Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Weight Loss and Obesity Management Market Size (2019-2030)
7.2 Europe Weight Loss and Obesity Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Weight Loss and Obesity Management Market Size by Country (2019-2024)
7.4 Europe Weight Loss and Obesity Management Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Weight Loss and Obesity Management Market Size (2019-2030)
8.2 Asia-Pacific Weight Loss and Obesity Management Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Weight Loss and Obesity Management Market Size by Region (2019-2024)
8.4 Asia-Pacific Weight Loss and Obesity Management Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Weight Loss and Obesity Management Market Size (2019-2030)
9.2 Latin America Weight Loss and Obesity Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Weight Loss and Obesity Management Market Size by Country (2019-2024)
9.4 Latin America Weight Loss and Obesity Management Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Weight Loss and Obesity Management Market Size (2019-2030)
10.2 Middle East & Africa Weight Loss and Obesity Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Weight Loss and Obesity Management Market Size by Country (2019-2024)
10.4 Middle East & Africa Weight Loss and Obesity Management Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Detail
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Weight Loss and Obesity Management Introduction
11.1.4 Novo Nordisk Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.1.5 Novo Nordisk Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Weight Loss and Obesity Management Introduction
11.2.4 GlaxoSmithKline Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Weight Loss and Obesity Management Introduction
11.3.4 Roche Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Allergan
11.4.1 Allergan Company Detail
11.4.2 Allergan Business Overview
11.4.3 Allergan Weight Loss and Obesity Management Introduction
11.4.4 Allergan Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.4.5 Allergan Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Weight Loss and Obesity Management Introduction
11.5.4 Johnson & Johnson Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Weight Loss and Obesity Management Introduction
11.6.4 Medtronic Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.6.5 Medtronic Recent Development
11.7 Vivus Inc
11.7.1 Vivus Inc Company Detail
11.7.2 Vivus Inc Business Overview
11.7.3 Vivus Inc Weight Loss and Obesity Management Introduction
11.7.4 Vivus Inc Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.7.5 Vivus Inc Recent Development
11.8 Eisai
11.8.1 Eisai Company Detail
11.8.2 Eisai Business Overview
11.8.3 Eisai Weight Loss and Obesity Management Introduction
11.8.4 Eisai Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.8.5 Eisai Recent Development
11.9 Nalpropion Pharmaceuticals
11.9.1 Nalpropion Pharmaceuticals Company Detail
11.9.2 Nalpropion Pharmaceuticals Business Overview
11.9.3 Nalpropion Pharmaceuticals Weight Loss and Obesity Management Introduction
11.9.4 Nalpropion Pharmaceuticals Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.9.5 Nalpropion Pharmaceuticals Recent Development
11.10 ReShape Lifesciences
11.10.1 ReShape Lifesciences Company Detail
11.10.2 ReShape Lifesciences Business Overview
11.10.3 ReShape Lifesciences Weight Loss and Obesity Management Introduction
11.10.4 ReShape Lifesciences Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.10.5 ReShape Lifesciences Recent Development
11.11 Obalon Therapeutics
11.11.1 Obalon Therapeutics Company Detail
11.11.2 Obalon Therapeutics Business Overview
11.11.3 Obalon Therapeutics Weight Loss and Obesity Management Introduction
11.11.4 Obalon Therapeutics Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.11.5 Obalon Therapeutics Recent Development
11.12 Allurion Technologies
11.12.1 Allurion Technologies Company Detail
11.12.2 Allurion Technologies Business Overview
11.12.3 Allurion Technologies Weight Loss and Obesity Management Introduction
11.12.4 Allurion Technologies Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.12.5 Allurion Technologies Recent Development
11.13 Beijing Noble Laser Technology
11.13.1 Beijing Noble Laser Technology Company Detail
11.13.2 Beijing Noble Laser Technology Business Overview
11.13.3 Beijing Noble Laser Technology Weight Loss and Obesity Management Introduction
11.13.4 Beijing Noble Laser Technology Revenue in Weight Loss and Obesity Management Business (2019-2024)
11.13.5 Beijing Noble Laser Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Weight Loss and Obesity Management Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Weight Loss and Obesity Management Devices
Table 3. Key Players of Weight Loss and Obesity Management Drugs
Table 4. Global Weight Loss and Obesity Management Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Weight Loss and Obesity Management Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Weight Loss and Obesity Management Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Weight Loss and Obesity Management Market Share by Region (2019-2024)
Table 8. Global Weight Loss and Obesity Management Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Weight Loss and Obesity Management Market Share by Region (2025-2030)
Table 10. Weight Loss and Obesity Management Market Trends
Table 11. Weight Loss and Obesity Management Market Drivers
Table 12. Weight Loss and Obesity Management Market Challenges
Table 13. Weight Loss and Obesity Management Market Restraints
Table 14. Global Weight Loss and Obesity Management Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Weight Loss and Obesity Management Market Share by Players (2019-2024)
Table 16. Global Top Weight Loss and Obesity Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss and Obesity Management as of 2023)
Table 17. Ranking of Global Top Weight Loss and Obesity Management Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Weight Loss and Obesity Management Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Weight Loss and Obesity Management Product Solution and Service
Table 21. Date of Enter into Weight Loss and Obesity Management Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Weight Loss and Obesity Management Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Weight Loss and Obesity Management Revenue Market Share by Type (2019-2024)
Table 25. Global Weight Loss and Obesity Management Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Weight Loss and Obesity Management Revenue Market Share by Type (2025-2030)
Table 27. Global Weight Loss and Obesity Management Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Weight Loss and Obesity Management Revenue Market Share by Application (2019-2024)
Table 29. Global Weight Loss and Obesity Management Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Weight Loss and Obesity Management Revenue Market Share by Application (2025-2030)
Table 31. North America Weight Loss and Obesity Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Weight Loss and Obesity Management Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Weight Loss and Obesity Management Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Weight Loss and Obesity Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Weight Loss and Obesity Management Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Weight Loss and Obesity Management Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Weight Loss and Obesity Management Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Weight Loss and Obesity Management Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Weight Loss and Obesity Management Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Weight Loss and Obesity Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Weight Loss and Obesity Management Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Weight Loss and Obesity Management Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Weight Loss and Obesity Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Weight Loss and Obesity Management Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Weight Loss and Obesity Management Market Size by Country (2025-2030) & (US$ Million)
Table 46. Novo Nordisk Company Detail
Table 47. Novo Nordisk Business Overview
Table 48. Novo Nordisk Weight Loss and Obesity Management Product
Table 49. Novo Nordisk Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 50. Novo Nordisk Recent Development
Table 51. GlaxoSmithKline Company Detail
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Weight Loss and Obesity Management Product
Table 54. GlaxoSmithKline Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 55. GlaxoSmithKline Recent Development
Table 56. Roche Company Detail
Table 57. Roche Business Overview
Table 58. Roche Weight Loss and Obesity Management Product
Table 59. Roche Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Allergan Company Detail
Table 62. Allergan Business Overview
Table 63. Allergan Weight Loss and Obesity Management Product
Table 64. Allergan Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 65. Allergan Recent Development
Table 66. Johnson & Johnson Company Detail
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Weight Loss and Obesity Management Product
Table 69. Johnson & Johnson Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Medtronic Company Detail
Table 72. Medtronic Business Overview
Table 73. Medtronic Weight Loss and Obesity Management Product
Table 74. Medtronic Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 75. Medtronic Recent Development
Table 76. Vivus Inc Company Detail
Table 77. Vivus Inc Business Overview
Table 78. Vivus Inc Weight Loss and Obesity Management Product
Table 79. Vivus Inc Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 80. Vivus Inc Recent Development
Table 81. Eisai Company Detail
Table 82. Eisai Business Overview
Table 83. Eisai Weight Loss and Obesity Management Product
Table 84. Eisai Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 85. Eisai Recent Development
Table 86. Nalpropion Pharmaceuticals Company Detail
Table 87. Nalpropion Pharmaceuticals Business Overview
Table 88. Nalpropion Pharmaceuticals Weight Loss and Obesity Management Product
Table 89. Nalpropion Pharmaceuticals Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 90. Nalpropion Pharmaceuticals Recent Development
Table 91. ReShape Lifesciences Company Detail
Table 92. ReShape Lifesciences Business Overview
Table 93. ReShape Lifesciences Weight Loss and Obesity Management Product
Table 94. ReShape Lifesciences Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 95. ReShape Lifesciences Recent Development
Table 96. Obalon Therapeutics Company Detail
Table 97. Obalon Therapeutics Business Overview
Table 98. Obalon Therapeutics Weight Loss and Obesity Management Product
Table 99. Obalon Therapeutics Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 100. Obalon Therapeutics Recent Development
Table 101. Allurion Technologies Company Detail
Table 102. Allurion Technologies Business Overview
Table 103. Allurion Technologies Weight Loss and Obesity Management Product
Table 104. Allurion Technologies Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 105. Allurion Technologies Recent Development
Table 106. Beijing Noble Laser Technology Company Detail
Table 107. Beijing Noble Laser Technology Business Overview
Table 108. Beijing Noble Laser Technology Weight Loss and Obesity Management Product
Table 109. Beijing Noble Laser Technology Revenue in Weight Loss and Obesity Management Business (2019-2024) & (US$ Million)
Table 110. Beijing Noble Laser Technology Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Weight Loss and Obesity Management Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Weight Loss and Obesity Management Market Share by Type: 2023 VS 2030
Figure 3. Weight Loss and Obesity Management Devices Features
Figure 4. Weight Loss and Obesity Management Drugs Features
Figure 5. Global Weight Loss and Obesity Management Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Weight Loss and Obesity Management Market Share by Application: 2023 VS 2030
Figure 7. Men Case Studies
Figure 8. Women Case Studies
Figure 9. Weight Loss and Obesity Management Report Years Considered
Figure 10. Global Weight Loss and Obesity Management Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Weight Loss and Obesity Management Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Weight Loss and Obesity Management Market Share by Region: 2023 VS 2030
Figure 13. Global Weight Loss and Obesity Management Market Share by Players in 2023
Figure 14. Global Top Weight Loss and Obesity Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight Loss and Obesity Management as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Weight Loss and Obesity Management Revenue in 2023
Figure 16. North America Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Weight Loss and Obesity Management Market Share by Country (2019-2030)
Figure 18. United States Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Weight Loss and Obesity Management Market Share by Country (2019-2030)
Figure 22. Germany Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Weight Loss and Obesity Management Market Share by Region (2019-2030)
Figure 30. China Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Weight Loss and Obesity Management Market Share by Country (2019-2030)
Figure 38. Mexico Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Weight Loss and Obesity Management Market Share by Country (2019-2030)
Figure 42. Turkey Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Weight Loss and Obesity Management Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Novo Nordisk Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 46. Roche Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 47. Allergan Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 49. Medtronic Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 50. Vivus Inc Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 51. Eisai Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 52. Nalpropion Pharmaceuticals Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 53. ReShape Lifesciences Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 54. Obalon Therapeutics Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 55. Allurion Technologies Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 56. Beijing Noble Laser Technology Revenue Growth Rate in Weight Loss and Obesity Management Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
